87 related articles for article (PubMed ID: 17387688)
1. A variable poly-T sequence modulates alpha-synuclein isoform expression and is associated with aging.
Beyer K; Humbert J; Ferrer A; Lao JI; Latorre P; Lopez D; Tolosa E; Ferrer I; Ariza A
J Neurosci Res; 2007 May; 85(7):1538-46. PubMed ID: 17387688
[TBL] [Abstract][Full Text] [Related]
2. Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease.
Beyer K; Humbert J; Ferrer A; Lao JI; Carrato C; López D; Ferrer I; Ariza A
Neuroreport; 2006 Aug; 17(12):1327-30. PubMed ID: 16951579
[TBL] [Abstract][Full Text] [Related]
3. Decreased alpha-synuclein expression in the aging mouse substantia nigra.
Mak SK; McCormack AL; Langston JW; Kordower JH; Di Monte DA
Exp Neurol; 2009 Dec; 220(2):359-65. PubMed ID: 19800328
[TBL] [Abstract][Full Text] [Related]
4. Abnormal alpha-synuclein solubility, aggregation and nitration in the frontal cortex in Pick's disease.
Dalfó E; Martinez A; Muntané G; Ferrer I
Neurosci Lett; 2006 May; 400(1-2):125-9. PubMed ID: 16516382
[TBL] [Abstract][Full Text] [Related]
5. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B
Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219
[TBL] [Abstract][Full Text] [Related]
6. [The wild-type alpha-synuclein over-expression to induce the protein aberrant aggregation of alpha-synuclein in HEK293 cells in vitro].
Chen T; Tang BS; Liao XP; Yan XX; Zhang RX; Zhang YH; Tang JG; Cao L; Guo JF; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):19-22. PubMed ID: 16456779
[TBL] [Abstract][Full Text] [Related]
7. Dietary restriction modulates alpha-synuclein expression in the aging rat cortex and hippocampus.
Mladenovic A; Perovic M; Tanic N; Petanceska S; Ruzdijic S; Kanazir S
Synapse; 2007 Sep; 61(9):790-4. PubMed ID: 17568432
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein deficiency affects brain Foxp1 expression and ultrasonic vocalization.
Kurz A; Wöhr M; Walter M; Bonin M; Auburger G; Gispert S; Schwarting RK
Neuroscience; 2010 Mar; 166(3):785-95. PubMed ID: 20056137
[TBL] [Abstract][Full Text] [Related]
9. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
Schell H; Hasegawa T; Neumann M; Kahle PJ
Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
[TBL] [Abstract][Full Text] [Related]
10. [Role of genetics in the etiology of synucleinopathies].
Elcoroaristizabal Martín X; Gómez Busto F; González Fernández MC; de Pancorbo MM
Rev Esp Geriatr Gerontol; 2011 Oct; 46 Suppl 1():3-11. PubMed ID: 22152908
[TBL] [Abstract][Full Text] [Related]
11. Expression of alpha-synuclein is increased in the hippocampus of rats with high levels of innate anxiety.
Chiavegatto S; Izidio GS; Mendes-Lana A; Aneas I; Freitas TA; Torrão AS; Conceição IM; Britto LR; Ramos A
Mol Psychiatry; 2009 Sep; 14(9):894-905. PubMed ID: 18427558
[TBL] [Abstract][Full Text] [Related]
12. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
Vitale L; Frabetti F; Huntsman SA; Canaider S; Casadei R; Lenzi L; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
BMC Cancer; 2007 Apr; 7():66. PubMed ID: 17442112
[TBL] [Abstract][Full Text] [Related]
13. Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms.
Halliday GM; McCann H
Exp Neurol; 2008 Jan; 209(1):12-21. PubMed ID: 17706644
[TBL] [Abstract][Full Text] [Related]
14. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
[TBL] [Abstract][Full Text] [Related]
15. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
Gallardo G; Schlüter OM; Südhof TC
Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases.
Beyer K; Domingo-Sábat M; Lao JI; Carrato C; Ferrer I; Ariza A
Neurogenetics; 2008 Feb; 9(1):15-23. PubMed ID: 17955272
[TBL] [Abstract][Full Text] [Related]
17. Expression of alpha-synuclein in different brain parts of adult and aged rats.
Adamczyk A; Solecka J; Strosznajder JB
J Physiol Pharmacol; 2005 Mar; 56(1):29-37. PubMed ID: 15795473
[TBL] [Abstract][Full Text] [Related]
18. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.
Noguchi-Shinohara M; Tokuda T; Yoshita M; Kasai T; Ono K; Nakagawa M; El-Agnaf OM; Yamada M
Brain Res; 2009 Jan; 1251():1-6. PubMed ID: 19071095
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.
Beyer K; Domingo-Sàbat M; Humbert J; Carrato C; Ferrer I; Ariza A
Neurogenetics; 2008 Jul; 9(3):163-72. PubMed ID: 18335262
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers.
Beyer K
Acta Neuropathol; 2006 Sep; 112(3):237-51. PubMed ID: 16845533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
